A detailed history of Fulcrum Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Fulcrum Capital LLC holds 3,698 shares of JNJ stock, worth $574,928. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,698
Previous 3,602 2.67%
Holding current value
$574,928
Previous $526,000 13.88%
% of portfolio
0.13%
Previous 0.12%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$145.48 - $167.38 $13,966 - $16,068
96 Added 2.67%
3,698 $599,000
Q1 2024

Apr 17, 2024

BUY
$155.22 - $162.74 $20,023 - $20,993
129 Added 3.71%
3,602 $569,000
Q4 2023

Jan 10, 2024

BUY
$145.6 - $158.88 $505,668 - $551,790
3,473 New
3,473 $544,000
Q2 2023

Jul 27, 2023

SELL
$154.35 - $166.11 $9,106 - $9,800
-59 Reduced 1.68%
3,450 $571,000
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $15,105 - $18,026
-100 Reduced 2.77%
3,509 $543,000
Q4 2022

Jan 24, 2023

BUY
$160.2 - $179.79 $128,159 - $143,832
800 Added 28.48%
3,609 $0
Q3 2022

Oct 17, 2022

BUY
$161.33 - $179.52 $4,839 - $5,385
30 Added 1.08%
2,809 $459,000
Q2 2022

Aug 03, 2022

SELL
$168.19 - $186.01 $1,177 - $1,302
-7 Reduced 0.25%
2,779 $493,000
Q1 2022

May 05, 2022

SELL
$158.14 - $179.59 $25,302 - $28,734
-160 Reduced 5.43%
2,786 $494,000
Q4 2021

Jan 25, 2022

SELL
$155.93 - $173.01 $87,944 - $97,577
-564 Reduced 16.07%
2,946 $504,000
Q3 2021

Oct 21, 2021

SELL
$161.5 - $179.47 $45,220 - $50,251
-280 Reduced 7.39%
3,510 $567,000
Q2 2021

Jul 30, 2021

SELL
$159.48 - $171.07 $5.75 Million - $6.17 Million
-36,042 Reduced 90.49%
3,790 $624,000
Q1 2021

Apr 12, 2021

SELL
$153.07 - $170.48 $84,188 - $93,764
-550 Reduced 1.36%
39,832 $6.55 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $411,604 - $472,454
3,002 Added 8.03%
40,382 $6.36 Million
Q3 2020

Oct 21, 2020

SELL
$140.38 - $153.83 $408,646 - $447,799
-2,911 Reduced 7.22%
37,380 $5.57 Million
Q2 2020

Jul 27, 2020

SELL
$128.81 - $155.51 $458,048 - $552,993
-3,556 Reduced 8.11%
40,291 $5.67 Million
Q1 2020

May 01, 2020

SELL
$111.14 - $153.99 $134,590 - $186,481
-1,211 Reduced 2.69%
43,847 $5.75 Million
Q4 2019

Feb 03, 2020

BUY
$127.5 - $146.44 $202,852 - $232,986
1,591 Added 3.66%
45,058 $6.57 Million
Q3 2019

Oct 31, 2019

BUY
$126.95 - $142.14 $192,202 - $215,199
1,514 Added 3.61%
43,467 $3,000
Q2 2019

Jul 29, 2019

SELL
$131.15 - $144.24 $808,802 - $889,528
-6,167 Reduced 12.82%
41,953 $5.84 Million
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $274,698 - $305,441
2,185 Added 4.76%
48,120 $6.73 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $422,078 - $507,978
-3,436 Reduced 6.96%
45,935 $5.93 Million
Q3 2018

Nov 06, 2018

BUY
$121.58 - $142.88 $209,847 - $246,610
1,726 Added 3.62%
49,371 $6.82 Million
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $25,790 - $28,460
-216 Reduced 0.45%
47,645 $5.78 Million
Q1 2018

May 09, 2018

BUY
$125.1 - $148.14 $156,249 - $185,026
1,249 Added 2.68%
47,861 $6.13 Million
Q4 2017

Jan 30, 2018

BUY
$131.22 - $143.62 $6.12 Million - $6.69 Million
46,612
46,612 $6.51 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fulcrum Capital LLC Portfolio

Follow Fulcrum Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.